Web application against cancer

• April 26, 2024

The key to advance in the treatment and investigation against Cancer is to create large-scale connections that bring together patients, doctors and scientists, no matter where they live or work, and Marty Tenenbaum will try it in a new Web Application .

Tenenbaum, entrepreneur of shops in Internet, was diagnosed with one of the types of skin cancer more devastating, melanoma . He managed to win the battle againstl cancer , but he still remembers the frustration he felt when analyzing all the treatment options, clinical tests and investigations he went through.

The Cancer Commons application integrates existing information on different types of melanoma and the experimental treatments most promising The patients or your doctors upload to the network how much of the disease has progressed, how it started, and if there is evidence they have discovered genetic mutations that contribute to the spread of cancer.

The information that the patient uploads to application is analyzed by a panel of experts and tells you what type of cancer is specific, what type of drugs are most recommended in that case and if there are experimental treatments that are being tested.

"Now he just tried to integrate all the pieces that are needed to create a Real and rational attack against cancer ", Mentions the 67-year-old businessman. The way to do it is to take people out of their individual laboratories, office and hospital and make them collaborate in a way that before the Internet and mobile applications was impossible.

"How much cancer could become a manageable disease if we only knew what we already know?" Marty Tenenbaum is a promoter of the new movement of "open science", which supports a greater platform in order to share research and reduce legal, institutional, financial and geographic barriers, to bring together the brightest minds and information in one place and solve the most difficult science problems.

The application was created by CollabRx, a start-up of Tenenbaum. It's free for doctors and patients . All the information generated will be open to the public. The monetization of the service will be done through sponsorships of pharmaceutical companies, even if it does not promote specific medications.

Source: Associated Press